01-09-2006 | Phase II Studies
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane
Published in: Investigational New Drugs | Issue 5/2006
Login to get access